Noninvasive test may predict retinopathy in type 1 diabetes patients

06/17/2011 | Irish Medical Times/Medical Publications Ltd.

Using noninvasive retinal testing to measure arteriolar length/diameter ratio and tortuosity may help predict retinopathy in patients with type 1 diabetes, a study in Diabetes Care suggests. Patients with the lowest LDRa and highest arterial tortuosity rates were at risk of developing diabetes-related retinopathy by up to 80% and 50% respectively, experts said.

View Full Article in:

Irish Medical Times/Medical Publications Ltd.

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ